| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.057 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |